{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:49:08Z","timestamp":1791506948906,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Xiamen Major Scientific Research Project for High-Quality Development","award":["2024GZL-ZD10"],"award-info":[{"award-number":["2024GZL-ZD10"]}]},{"name":"the Science and Technology Planning Project of Fujian Provincial Health Commission","award":["2023CXB007"],"award-info":[{"award-number":["2023CXB007"]}]},{"name":"the Science and Technology Projects of Xiamen City","award":["3502Z202374006"],"award-info":[{"award-number":["3502Z202374006"]}]},{"name":"the Natural Science Foundation of Fujian Province","award":["2023J011594"],"award-info":[{"award-number":["2023J011594"]}]},{"name":"the Innovation Research and Development Special Funds of the Municipality-province-ministry Co-constructed","award":["GJZXHYSW-2024-02"],"award-info":[{"award-number":["GJZXHYSW-2024-02"]}]},{"name":"the Xiamen Ocean and Fisheries Development Special Funds Program","award":["22CZP006HJ03"],"award-info":[{"award-number":["22CZP006HJ03"]}]},{"name":"the National Natural Science Foundation of China","award":["12575276"],"award-info":[{"award-number":["12575276"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-03079-5","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:29:27Z","timestamp":1784096967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Harnessing tumor-associated exosomal aminopeptidase N as a dual-function tool for monitoring and tackling chemoresistance in gastric cancer"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5323-153X","authenticated-orcid":false,"given":"Wangyu","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheru","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ende","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoteng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"3079_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3079_CR2","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(25)00052-2","volume":"405","author":"R Sundar","year":"2025","unstructured":"Sundar R, Nakayama I, Markar SR, Shitara K, van Laarhoven HWM, Janjigian YY, Smyth EC. Gastric cancer. Lancet. 2025;405:2087\u2013102.","journal-title":"Lancet"},{"key":"3079_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41392-024-02097-4","volume":"10","author":"T Zhan","year":"2025","unstructured":"Zhan T, Betge J, Schulte N, Dreikhausen L, Hirth M, Li M, Weidner P, Leipertz A, Teufel A, Ebert MP. Digestive cancers: mechanisms, therapeutics and management. Signal Transduct Target Ther. 2025;10:24.","journal-title":"Signal Transduct Target Ther"},{"key":"3079_CR4","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.7150\/ijbs.113709","volume":"21","author":"Q Wang","year":"2025","unstructured":"Wang Q, Xue F, Assaraf YG, Lin Y. Harnessing Natural Products to Surmount Drug Resistance in Gastric Cancer: Mechanisms and Therapeutic Perspectives. Int J Biol Sci. 2025;21:4604\u201328.","journal-title":"Int J Biol Sci"},{"key":"3079_CR5","doi-asserted-by":"publisher","first-page":"101200","DOI":"10.1016\/j.drup.2024.101200","volume":"79","author":"X Fan","year":"2025","unstructured":"Fan X, Han F, Wang H, Shu Z, Qiu B, Zeng F, Chen H, Wu Z, Lin Y, Lan Z, et al. YTHDF2-mediated m(6)A modification of ONECUT2 promotes stemness and oxaliplatin resistance in gastric cancer through transcriptionally activating TFPI. Drug Resist Updat. 2025;79:101200.","journal-title":"Drug Resist Updat"},{"key":"3079_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10120-013-0259-5","volume":"17","author":"H Shimada","year":"2014","unstructured":"Shimada H, Noie T, Ohashi M, Oba K, Takahashi Y. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer. 2014;17:26\u201333.","journal-title":"Gastric Cancer"},{"key":"3079_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer"},{"key":"3079_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12943-024-02215-4","volume":"24","author":"J Li","year":"2025","unstructured":"Li J, Wang J, Chen Z. Emerging role of exosomes in cancer therapy: progress and challenges. Mol Cancer. 2025;24:13.","journal-title":"Mol Cancer"},{"key":"3079_CR9","doi-asserted-by":"crossref","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.","DOI":"10.1126\/science.aau6977"},{"key":"3079_CR10","doi-asserted-by":"publisher","first-page":"217792","DOI":"10.1016\/j.canlet.2025.217792","volume":"626","author":"Z Jin","year":"2025","unstructured":"Jin Z, Zhang C, Shen L, Cao Y. Harnessing exosomes: From tumor immune escape to therapeutic innovation in gastric cancer immunotherapy. Cancer Lett. 2025;626:217792.","journal-title":"Cancer Lett"},{"key":"3079_CR11","doi-asserted-by":"publisher","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","volume":"16","author":"R Tenchov","year":"2022","unstructured":"Tenchov R, Sasso JM, Wang X, Liaw WS, Chen CA, Zhou QA. ExosomesNature\u2019s Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics. ACS Nano. 2022;16:17802\u201346.","journal-title":"ACS Nano"},{"key":"3079_CR12","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1136\/gutjnl-2024-333522","volume":"74","author":"ZR Cai","year":"2025","unstructured":"Cai ZR, Zheng YQ, Hu Y, Ma MY, Wu YJ, Liu J, Yang LP, Zheng JB, Tian T, Hu PS, et al. Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study. Gut. 2025;74:884\u201393.","journal-title":"Gut"},{"key":"3079_CR13","doi-asserted-by":"publisher","first-page":"113961","DOI":"10.1016\/j.jconrel.2025.113961","volume":"384","author":"X Shi","year":"2025","unstructured":"Shi X, Zhao X, He Y, Zhang L, Zheng X, Qin X, Li K, Li J, Wang Y, Dai L, Li X. Posttranslational remodeling micelle reverses cell-surface and exosomal PD-L1 immunosuppression in tumors resistant to PD-L1 antibody therapy. J Control Release. 2025;384:113961.","journal-title":"J Control Release"},{"key":"3079_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1158\/0008-5472.CAN-21-3432","volume":"83","author":"Y Pan","year":"2023","unstructured":"Pan Y, Lu X, Shu G, Cen J, Lu J, Zhou M, Huang K, Dong J, Li J, Lin H, et al. Extracellular Vesicle-Mediated Transfer of LncRNA IGFL2-AS1 Confers Sunitinib Resistance in Renal Cell Carcinoma. Cancer Res. 2023;83:103\u201316.","journal-title":"Cancer Res"},{"key":"3079_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cell.2014.09.051","volume":"159","author":"MC Boelens","year":"2014","unstructured":"Boelens MC, Wu TJ, Nabet BY, Xu B, Qiu Y, Yoon T, Azzam DJ, Twyman-Saint Victor C, Wiemann BZ, Ishwaran H, et al. Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell. 2014;159:499\u2013513.","journal-title":"Cell"},{"key":"3079_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/bjc.2017.18","volume":"116","author":"GK Patel","year":"2017","unstructured":"Patel GK, Khan MA, Bhardwaj A, Srivastava SK, Zubair H, Patton MC, Singh S, Khushman M, Singh AP. Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK. Br J Cancer. 2017;116:609\u201319.","journal-title":"Br J Cancer"},{"key":"3079_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12943-025-02254-5","volume":"24","author":"W Liu","year":"2025","unstructured":"Liu W, Niu J, Huo Y, Zhang L, Han L, Zhang N, Yang M. Role of circular RNAs in cancer therapy resistance. Mol Cancer. 2025;24:55.","journal-title":"Mol Cancer"},{"key":"3079_CR18","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ccell.2016.03.004","volume":"29","author":"L Qu","year":"2016","unstructured":"Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y, Chen W, Liu F, Sun W, Li XF, et al. Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA. Cancer Cell. 2016;29:653\u201368.","journal-title":"Cancer Cell"},{"key":"3079_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature14581","volume":"523","author":"SA Melo","year":"2015","unstructured":"Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari N, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015;523:177\u201382.","journal-title":"Nature"},{"key":"3079_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s11658-024-00676-5","volume":"29","author":"J Wang","year":"2024","unstructured":"Wang J, Zhang H, Li J, Ni X, Yan W, Chen Y, Shi T. Exosome-derived proteins in gastric cancer progression, drug resistance, and immune response. Cell Mol Biol Lett. 2024;29:157.","journal-title":"Cell Mol Biol Lett"},{"key":"3079_CR21","doi-asserted-by":"publisher","first-page":"108414","DOI":"10.1016\/j.isci.2023.108414","volume":"26","author":"J Wang","year":"2023","unstructured":"Wang J, Deng R, Chen S, Deng S, Hu Q, Xu B, Li J, He Z, Peng M, Lei S, et al. Helicobacter pylori CagA promotes immune evasion of gastric cancer by upregulating PD-L1 level in exosomes. iScience. 2023;26:108414.","journal-title":"iScience"},{"key":"3079_CR22","doi-asserted-by":"publisher","first-page":"9080","DOI":"10.1038\/s41467-025-64149-9","volume":"16","author":"C Liu","year":"2025","unstructured":"Liu C, Liu D, Zheng X, Guan J, Zhou X, Zhang H, Wang S, Li Q, Lu G, He J, Ma C. Munc13-4 mediates tumor immune evasion by regulating the sorting and secretion of PD-L1 via exosomes. Nat Commun. 2025;16:9080.","journal-title":"Nat Commun"},{"key":"3079_CR23","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1158\/1535-7163.MCT-16-0750","volume":"16","author":"W Cai","year":"2017","unstructured":"Cai W, Chen G, Luo Q, Liu J, Guo X, Zhang T, Ma F, Yuan L, Li B, Cai J. PMP22 Regulates Self-Renewal and Chemoresistance of Gastric Cancer Cells. Mol Cancer Ther. 2017;16:1187\u201398.","journal-title":"Mol Cancer Ther"},{"key":"3079_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41388-018-0406-x","volume":"38","author":"R Toshiyama","year":"2019","unstructured":"Toshiyama R, Konno M, Eguchi H, Takemoto H, Noda T, Asai A, Koseki J, Haraguchi N, Ueda Y, Matsushita K, et al. Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells. Oncogene. 2019;38:244\u201360.","journal-title":"Oncogene"},{"key":"3079_CR25","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.3892\/ijo.2017.4159","volume":"51","author":"C Dou","year":"2017","unstructured":"Dou C, Fang C, Zhao Y, Fu X, Zhang Y, Zhu D, Wu H, Liu H, Zhang J, Xu W, et al. BC-02 eradicates liver cancer stem cells by upregulating the ROS-dependent DNA damage. Int J Oncol. 2017;51:1775\u201384.","journal-title":"Int J Oncol"},{"key":"3079_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3892\/ijo.2016.3496","volume":"49","author":"M Yamashita","year":"2016","unstructured":"Yamashita M, Wada H, Eguchi H, Ogawa H, Yamada D, Noda T, Asaoka T, Kawamoto K, Gotoh K, Umeshita K, et al. A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma. Int J Oncol. 2016;49:89\u201398.","journal-title":"Int J Oncol"},{"key":"3079_CR27","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/hep.24222","volume":"53","author":"B Christ","year":"2011","unstructured":"Christ B, Stock P, Dollinger MM. CD13: Waving the flag for a novel cancer stem cell target. Hepatology. 2011;53:1388\u201390.","journal-title":"Hepatology"},{"key":"3079_CR28","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25:424\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3079_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317\u201331.","journal-title":"Cell"},{"key":"3079_CR30","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.biochi.2010.04.026","volume":"92","author":"A Mucha","year":"2010","unstructured":"Mucha A, Drag M, Dalton JP, Kafarski P. Metallo-aminopeptidase inhibitors. Biochimie. 2010;92:1509\u201329.","journal-title":"Biochimie"},{"key":"3079_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12943-024-01966-4","volume":"23","author":"C Deng","year":"2024","unstructured":"Deng C, Huo M, Chu H, Zhuang X, Deng G, Li W, Wei H, Zeng L, He Y, Liu H, et al. Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p\/STAT6 axis to promote gastric cancer progression. Mol Cancer. 2024;23:49.","journal-title":"Mol Cancer"},{"key":"3079_CR32","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1001\/jamasurg.2025.2493","volume":"160","author":"S Sui","year":"2025","unstructured":"Sui S, Xu C, Kanda M, Okugawa Y, Toiyama Y, Park JO, Hur H, Kim SC, Taketomi A, Kodera Y, et al. Exosomal Liquid Biopsy for the Early Detection of Gastric Cancer: The DESTINEX Multicenter Study. JAMA Surg. 2025;160:973\u201382.","journal-title":"JAMA Surg"},{"key":"3079_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13046-023-02827-6","volume":"42","author":"C Zhang","year":"2023","unstructured":"Zhang C, Wang H, Liu Q, Dai S, Tian G, Wei X, Li X, Zhao L, Shan B. LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement. J Exp Clin Cancer Res. 2023;42:246.","journal-title":"J Exp Clin Cancer Res"},{"key":"3079_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13046-025-03288-9","volume":"44","author":"Y Shen","year":"2025","unstructured":"Shen Y, Lin J, Jiang T, Shen X, Li Y, Fu Y, Xu P, Fang L, Chen Z, Huang H, et al. GC-derived exosomal circMAN1A2 promotes cancer progression and suppresses T-cell antitumour immunity by inhibiting FBXW11-mediated SFPQ degradation. J Exp Clin Cancer Res. 2025;44:24.","journal-title":"J Exp Clin Cancer Res"},{"key":"3079_CR35","doi-asserted-by":"publisher","first-page":"217758","DOI":"10.1016\/j.canlet.2025.217758","volume":"626","author":"W Li","year":"2025","unstructured":"Li W, Wei H, Liu J, Zhao Z, Wang F, Qiao L, Yin S, Zhang C, Huo M. Exosomal Biglycan promotes gastric cancer progression via M2 polarization and CXCL10-mediated JAK\/STAT1 activation. Cancer Lett. 2025;626:217758.","journal-title":"Cancer Lett"},{"key":"3079_CR36","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/s10120-018-0828-8","volume":"21","author":"JH Yoon","year":"2018","unstructured":"Yoon JH, Ham IH, Kim O, Ashktorab H, Smoot DT, Nam SW, Lee JY, Hur H, Park WS. Gastrokine 1 protein is a potential theragnostic target for gastric cancer. Gastric Cancer. 2018;21:956\u201367.","journal-title":"Gastric Cancer"},{"key":"3079_CR37","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1186\/s12967-024-05611-y","volume":"22","author":"H Li","year":"2024","unstructured":"Li H, Chen X, Zheng S, Han B, Zhang X, Zheng X, Lu Y, Sun Q, Hu X, Wu J. The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer. J Transl Med. 2024;22:821.","journal-title":"J Transl Med"},{"key":"3079_CR38","doi-asserted-by":"publisher","first-page":"151030","DOI":"10.1016\/j.ijbiomac.2026.151030","volume":"350","author":"I Pascual-Alonso","year":"2026","unstructured":"Pascual-Alonso I, Arrebola-S\u00e1nchez Y, Almeida-Garc\u00eda F, Fr\u00f3meta-Fuentes T, Ac\u00e9n-Ravelo T, Del Valle-Pelaiz S, Escandel-Barreto A, Ojeda Del Sol D, Vald\u00e9s-Tresanco ME, S\u00e1nchez-Ram\u00edrez B, et al. Biochemistry, physiology and implications in human diseases of mammalian aminopeptidase N: A review. Int J Biol Macromol. 2026;350:151030.","journal-title":"Int J Biol Macromol"},{"key":"3079_CR39","doi-asserted-by":"publisher","first-page":"188641","DOI":"10.1016\/j.bbcan.2021.188641","volume":"1876","author":"FM Barnieh","year":"2021","unstructured":"Barnieh FM, Loadman PM, Falconer RA. Is tumour-expressed aminopeptidase N (APN\/CD13) structurally and functionally unique? Biochim Biophys Acta Rev Cancer. 2021;1876:188641.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3079_CR40","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41419-020-2610-1","volume":"11","author":"M Zhai","year":"2020","unstructured":"Zhai M, Yang Z, Zhang C, Li J, Jia J, Zhou L, Lu R, Yao Z, Fu Z. APN-mediated phosphorylation of BCKDK promotes hepatocellular carcinoma metastasis and proliferation via the ERK signaling pathway. Cell Death Dis. 2020;11:396.","journal-title":"Cell Death Dis"},{"key":"3079_CR41","doi-asserted-by":"publisher","first-page":"115752","DOI":"10.1016\/j.ejmech.2023.115752","volume":"260","author":"G Jia","year":"2023","unstructured":"Jia G, Qi K, Hou B, Yue K, Xu T, Jiang Y, Li X. Design, synthesis, and biological evaluation of novel HDAC\/CD13 dual inhibitors for the treatment of cancer. Eur J Med Chem. 2023;260:115752.","journal-title":"Eur J Med Chem"},{"key":"3079_CR42","doi-asserted-by":"crossref","unstructured":"Lendeckel U, Karimi F, Al Abdulla R, Wolke C. The Role of the ectopeptidase APN\/CD13 in cancer. Biomedicines. 2023;11:724.","DOI":"10.3390\/biomedicines11030724"},{"key":"3079_CR43","doi-asserted-by":"crossref","unstructured":"Otsuki T, Nakashima T, Hamada H, Takayama Y, Akita S, Masuda T, Horimasu Y, Miyamoto S, Iwamoto H, Fujitaka K et al. Aminopeptidase N\/CD13 as a potential therapeutic target in malignant pleural mesothelioma. Eur Respir J. 2018;51:1701610.","DOI":"10.1183\/13993003.01610-2017"},{"key":"3079_CR44","doi-asserted-by":"crossref","unstructured":"Wang Q, Liang N, Fang X, Yang T, He X, Wang G, Wang N. Regulating the dormancy of cancer stem cells: a novel approach to preventing cancer relapse. Cell Death Dis. 2026;17:497.","DOI":"10.1038\/s41419-026-08707-z"},{"key":"3079_CR45","doi-asserted-by":"publisher","first-page":"e3029","DOI":"10.1038\/cddis.2017.406","volume":"8","author":"A Azimi","year":"2017","unstructured":"Azimi A, Tuominen R, Costa Svedman F, Caramuta S, Pernemalm M, Frostvik Stolt M, Kanter L, Kharaziha P, Lehti\u00f6 J, Hertzman Johansson C, et al. Silencing FLI or targeting CD13\/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells. Cell Death Dis. 2017;8:e3029.","journal-title":"Cell Death Dis"},{"key":"3079_CR46","doi-asserted-by":"publisher","first-page":"569","DOI":"10.20892\/j.issn.2095-3941.2020.0196","volume":"18","author":"J Ni","year":"2021","unstructured":"Ni J, Wang X, Shang Y, Li Y, Chen S. CD13 inhibition augments DR4-induced tumor cell death in a p-ERK1\/2-independent manner. Cancer Biol Med. 2021;18:569\u201386.","journal-title":"Cancer Biol Med"},{"key":"3079_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.biopha.2015.10.023","volume":"76","author":"ZP Sun","year":"2015","unstructured":"Sun ZP, Zhang J, Shi LH, Zhang XR, Duan Y, Xu WF, Dai G, Wang XJ. Aminopeptidase N inhibitor 4\u00a0cc synergizes antitumor effects of 5-fluorouracil on human liver cancer cells through ROS-dependent CD13 inhibition. Biomed Pharmacother. 2015;76:65\u201372.","journal-title":"Biomed Pharmacother"},{"key":"3079_CR48","doi-asserted-by":"crossref","unstructured":"Wu Y, Zhang Y, Shi X, Wu M, Sun M, Feng Y, Ma W, Jiang X, Fei D, Zhao M et al. Chronic stress-induced ANPEP drives liver cancer progression by increasing glutathione synthesis and inhibiting ferroptosis. J Clin Invest. 2026;136:e195685.","DOI":"10.1172\/JCI213290"},{"key":"3079_CR49","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s41568-025-00864-1","volume":"25","author":"A Wahida","year":"2025","unstructured":"Wahida A, Conrad M. Decoding ferroptosis for cancer therapy. Nat Rev Cancer. 2025;25:910\u201324.","journal-title":"Nat Rev Cancer"},{"key":"3079_CR50","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41419-019-2143-7","volume":"10","author":"M Gagliardi","year":"2019","unstructured":"Gagliardi M, Cotella D, Santoro C, Cor\u00e0 D, Barlev NA, Piacentini M, Corazzari M. Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. Cell Death Dis. 2019;10:902.","journal-title":"Cell Death Dis"},{"issue":"6","key":"3079_CR51","first-page":"e70349","volume":"2025","author":"G Shen","year":"2020","unstructured":"Shen G, Liu J, Wang Y, Deng Z, Deng F. Ferroptosis in Cancer and Inflammatory Diseases: Mechanisms and Therapeutic Implications. MedComm. 2020;2025(6):e70349.","journal-title":"MedComm"},{"key":"3079_CR52","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.molmed.2008.06.003","volume":"14","author":"P Mina-Osorio","year":"2008","unstructured":"Mina-Osorio P. The moonlighting enzyme CD13: old and new functions to target. Trends Mol Med. 2008;14:361\u201371.","journal-title":"Trends Mol Med"},{"key":"3079_CR53","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/jnci\/95.8.605","volume":"95","author":"Y Ichinose","year":"2003","unstructured":"Ichinose Y, Genka K, Koike T, Kato H, Watanabe Y, Mori T, Iioka S, Sakuma A, Ohta M. Randomized double-blind placebo-controlled trial of bestatin in patients with resected stage I squamous-cell lung carcinoma. J Natl Cancer Inst. 2003;95:605\u201310.","journal-title":"J Natl Cancer Inst"},{"key":"3079_CR54","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-019-0991-5","volume":"18","author":"L Mashouri","year":"2019","unstructured":"Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 2019;18:75.","journal-title":"Mol Cancer"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-03079-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03079-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03079-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:50:45Z","timestamp":1791503445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-03079-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3079"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-03079-5","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the International Ethical Guidelines for Biomedical Research Involving Human Subjects (CIOMS), and the research protocol was approved by the Clinical Research Ethics Committee of Zhongshan Hospital of Xiamen University (No. XMZSYYKY2021199). All animal procedures were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the Xiamen University Laboratory Animal Center (No. SYXK2018-0009).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"541"}}